Joint Annual Interagency Coordination Report, FY2023 (Texas Government Code 531.103)

Joint Interagency Coordination Report, fiscal year 2023 (5 pp.): coordination activities; OIG and MFCU key metrics (out of scope); Civil Medicaid Fraud Division table (cases opened 56, closed 157, pending 356, recovered $151,422,664); two significant cases of $2 million or more, both with relator portions; ongoing cases (Medical Diagnostic Laboratories, Gilead, Malouf, LabCorp, Pfizer/Tris) without amounts. Recovery total already recorded. Added the three case counts and the 2 matters as cases. The Malouf $16 million judgment is not a case here (no relator mentioned). Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 4 cases (4 pending government suits or claims). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Added first appearances of Medical Diagnostic Laboratories, Gilead, Pfizer/Tris Pharma/Ketan Mehta and Tris Pharma/Ketan Mehta as pending; the Malouf and LabCorp mentions repeat earlier reports (LabCorp: trial court granted summary judgment to the defendant, State appealing; no amount, not a new case).